Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
Prostate cancer and breast cancer are the most common cancers worldwide. Anti-tumor therapies are long and exhaustive for the patients. The real-time monitoring of the healing progression could be a useful tool to evaluate therapeutic response. Blood-based biosources like circulating tumor cells (CT...
Main Authors: | Gerit Theil, Paolo Fornara, Joanna Bialek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3782 |
Similar Items
-
Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
by: Gerit Theil, et al.
Published: (2021-07-01) -
Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
by: Gerit Theil, et al.
Published: (2022-02-01) -
Breast cancer circulating tumor cells
by: Maria Joao Carvalho, et al.
Published: (2011-12-01) -
Circulating Tumor Cells in Prostate Cancer
by: Brian Hu, et al.
Published: (2013-12-01) -
Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
by: Bianca C. T. Flores, et al.
Published: (2021-08-01)